This Government Contract opportunity from Department Of Defense was posted on June 21, 2019. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

TRICARE Pharmacy Program RFI

Closed

HT9402-19-R-0004Federal

Submission Closed07/19/2019, 10:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 446110

New

SLED

Correctional Healthcare & Pharmacy ServicesThe Correctional Healthcare and Pharmacy Services subcontract involves providing essential pharmaceuticals and medical care for prime contractors operating within Florida Department of Corrections facilities. The scope of work includes the comprehensive management of facility pharmacies and the dispensing of medications in strict accordance with the August 2026 Alphabetical State Drug Formulary. Additionally, the provider is responsible for pharmaceutical supply chain management and the delivery of medical records. Compliance is a critical component of this agreement, requiring strict adherence to HIPAA regulations and Florida Department of Corrections Health Service Bulletins. This opportunity falls under NAICS code 446110, with a response deadline set for December 8, 2026.

Florida Department of Corrections

POSTED

DEADLINE

Pharmaceutical Product Supply and PackagingThis subcontract for Pharmaceutical Product Supply and Packaging involves providing medication sourcing, packaging, and dispensing services for prime contractors operating at Birmingham Green healthcare facility projects. The selected provider is responsible for sourcing medications based on a specific formulary, managing contingency medication boxes, and ensuring all products are delivered to the facility. To qualify, the contractor must maintain proper pharmacy licensure and utilize pharmaceutical-grade packaging and dispensing systems. The project is managed under the Northern Virginia Health Center Commission in Virginia, with the place of performance located in Manassas. The solicitation was posted on October 1, 2026, and requires responses by October 30, 2026. This opportunity falls under NAICS code 446110, focusing on the specialized supply and distribution of pharmaceutical products.

Northern Virginia Health Center Commission

POSTED

DEADLINE

Pharmacy ServicesThis subcontract for Pharmacy Services supports prime contractors operating Department of Justice Federal Bureau of Prisons Residential Reentry Center projects in Eugene. The selected provider is responsible for the comprehensive supply and management of medications, ensuring all dispensing activities align with BOP pharmacy standards and medication security protocols established under P.S. 6360.01. The scope of work requires the deployment of licensed pharmacists and pharmacy technicians to manage medication dispensing and maintain rigorous pharmacy records. This opportunity falls under NAICS code 446110, with a response deadline set for October 30, 2026.

Residential Reentry - Co

POSTED

DEADLINE

Prescription Medication and Dosage ManagementThis subcontract opportunity, titled Prescription Medication and Dosage Management, supports prime contractors working on H-GAC Older Americans Act projects. The selected provider will be responsible for dispensing prescription medications and implementing dosage alert systems and software designed to connect individuals with reduced-cost prescription services. To be eligible, the provider must be a licensed pharmacy and maintain full HIPAA compliance to ensure the secure handling of patient information. The contract is managed by the Community and Environmental Area Agency on Aging in Texas under NAICS code 446110. It involves the delivery of medications and the deployment of active dosage alert systems. The response deadline for this opportunity is July 29, 2027.

Community & Environmental - Area Agency on Aging

POSTED

DEADLINE

Study Agent Labeling and DistributionThis subcontract with the National Institutes of Health under the Department of Health and Human Services focuses on the labeling and distribution of study agents for prime contractors involved in NIAID clinical trials. The selected provider is responsible for pharmacy management, cold-chain distribution, and the delivery of medications, requiring specific pharmacy licensure and the ability to maintain blinding and masking protocols. The project is categorized under NAICS code 446110 and was posted on June 16, 2026, with a response deadline of July 5, 2029. The primary objective is to ensure the secure and professional handling of study agents to support the integrity of clinical research operations.

National Institutes Of Health

POSTED

DEADLINE

Pharmacy & Drug Order Processing ServicesThis subcontract for Pharmacy and Drug Order Processing Services supports prime contractors operating within County of Orange inpatient psychiatric facilities. The selected provider is responsible for managing the end-to-end processing of medication orders, ensuring accurate dispensing, and overseeing all pharmacy logistics to guarantee the timely delivery of prescribed medications. The service provider must be a licensed pharmacy and maintain strict compliance with all California pharmacy laws and medical regulations. This opportunity is managed by the Health Care Agency for the state of California under NAICS code 446110, with a response deadline set for March 31, 2027.

POSTED

DEADLINE

Specialty Pharmacy Fulfillment of Lenalidomide (Revlimid)The contract involves the specialty pharmacy fulfillment and delivery of Lenalidomide (Revlimid), a medication used primarily in the treatment of certain cancers and blood disorders, to patients of the Department of Veterans Affairs (VA). The contractor is responsible for dispensing either branded or therapeutically equivalent versions of Lenalidomide in varying strengths. This service must comply with Risk Evaluation and Mitigation Strategies (REMS) protocols, ensuring safe and effective use of the medication. Essential contract activities include verifying prescriptions, conducting patient outreach to support medication adherence and understanding, securely packaging the medication, and ensuring delivery is confirmed by obtaining signatures upon receipt. This subcontract is issued by the 252-NETWORK Contract Office 12 under the Department of Veterans Affairs and aligns with NAICS code 446110, which typically covers pharmacies and drug stores. While specific performance location details and points of contact are not provided, the contract underscores the importance of compliance with federal safety standards and thorough patient management. The seamless coordination of prescription verification, patient communication, packaging, and secure delivery highlights the contractor’s critical role in supporting VA patients’ access to this specialized pharmaceutical therapy.

252-NETWORK Contract Office 12 (36C252)

POSTED

DEADLINE

Specialty Pharmacy Dispensing of Lenalidomide (Revlimid)

252-NETWORK Contract Office 12 (36C252)

POSTED

DEADLINE

Specialty Pharmacy Dispensing & REMS-Compliant Drug FulfillmentThis contract involves the dispensing of Lenalidomide in various dosages specifically to Veterans, ensuring strict adherence to the FDA's Risk Evaluation and Mitigation Strategies (REMS) program. The responsibilities include comprehensive patient counseling, monitoring of medication adherence, and coordinating secure delivery to ensure safe and compliant drug fulfillment. The contract is a subcontract under the Department of Veterans Affairs, aiming to support specialty pharmacy services with a focus on compliance and patient safety. The solicitation lacks a specified number and detailed location information but is categorized under NAICS code 446110, which pertains to pharmacies and drug stores. The contract was posted in late November 2025 and is managed by the 252-NETWORK Contract Office 12 within the Department of Veterans Affairs. This engagement underscores the importance of specialized pharmaceutical care within the VA system, emphasizing regulatory compliance, patient support, and secure distribution channels to meet the needs of the Veteran population.

252-NETWORK Contract Office 12 (36C252)

POSTED

11 months ago

DEADLINE

N/A

General Info

Agency

Department Of Defense → Defense Health Agency

NAICS

446110 - Pharmacies and Drug Stores

Place of Performance

Set-Aside

NONE

Documents

Industry_Day_Presentation_3_Apr_2019_FINAL.pdf

RFI__TRICARE_Pharmacy_20190201.docx

RFI__TRICARE_Pharmacy_20190207.docx

RFI__TRICARE_Pharmacy_201907.docx

TPharm_Industry_Webinar_Invitation_20190403.pdf

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

4 updates

PhaseClosed

PostedFeb 1

special-notice

Notice updatedFeb 7

The notice description changed. The point of contact changed.

Notice updatedMar 21

Response deadline changed from Feb 23, 2019 to Mar 28, 2019. The notice description changed.

Notice updatedApr 3

Response deadline changed from Mar 28, 2019 to Apr 5, 2019. The notice description changed.

Notice updatedJun 21

Response deadline changed from Apr 5, 2019 to Jul 19, 2019. The notice description changed.

Response DeadlineJul 19

Deadline has passed

Submission Closed

07/19/2019, 10:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Health Agency

Contacts1 person available

OfficeAURORA, CO, 80011, USA

Organization / AgencyDepartment Of Defense → Defense Health Agency

Office AddressAURORA, CO, 80011, USA

Contacts

Hilary MeckelContracting Officer

contact@example.gov

Full Description

20190621 UPDATED RFI 1. This announcement constitutes a Request for Information (RFI). This announcement does not constitute a commitment, implied or otherwise that a solicitation will be issued. This is not a request for proposal (RFP) or an invitation for bids (IFB). 2. Please note that the collection of this requested information does not obligate the U.S. Government to incorporate any solicited comments nor does it obligate the Government to procure the services. Responses to this RFI will not be returned. The Government is not liable to pay any costs associated with companies responding to this RFI. 3. All information received resulting from this RFI will be used by the Defense Health Agency (DHA) for acquisition planning and market research purposes only. However, your response may be releasable to the public under the Freedom of Information Act (FOIA). If you wish the DHA to consider any portion of your response as "confidential commercial information", you should clearly mark the portion as "confidential commercial information". 4. The Defense Health Agency (DHA), at its discretion, may request respondents to this RFI to elaborate on information in their written response. Respondents to this RFI will not be notified of any results derived from a review of the information provided. 5. The DHA invites all interested parties to submit a written response to this Request for Information (RFI). This RFI is issued for the sole purpose of conducting market research in accordance with the Federal Acquisition Regulation (FAR) Part 10. 6. Please respond to as many or as few of the questions posed. The questions cover a broad range of topics that may not be applicable to all responders.